Redesign Science, the company using computational chemistry to enhance molecular drug discovery, has raised $2M in Seed funding from investors that include Morningside Venture Capital, Third Kind Venture Capital, Refactor Capital, Notation Capital, and Thomas Weingarten. Redesign Science was founded by David Rooklin in 2017.
The AlleyWatch audience is driving progress and innovation on a global scale. With its regional media properties, AlleyWatch serves as the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including sponsoring a piece like this, which will be read by the vast majority of key influencers in the entrepreneurial universe. Find out more here.